MyFinsight
Home
Blog
About
INGREZZANet Product Sales
$716,500K
(14.75%↑ Y/Y)
CRENESSITYNet Product Sales
$183,500K
(244.92%↑ Y/Y)
VYKATXRNet Product Sales
$54,300K
Other Revenue Royalty
Earnings
$4,700K
Total revenues
$959,000K
(39.49%↑ Y/Y)
Investment income and
other, net
$12,400K
(-39.81%↓ Y/Y)
Unrealized loss (gain) on
equity investments
$1,200K
(117.91%↑ Y/Y)
Operating income
$151,500K
(4.05%↑ Y/Y)
Total other income,
net
$10,700K
(-23.02%↓ Y/Y)
Total operating
expenses
$807,500K
(49.01%↑ Y/Y)
Interest expense
$2,900K
Income before
provision for income taxes
$162,200K
(1.69%↑ Y/Y)
Selling, general, and
administrative
$439,700K
(53.58%↑ Y/Y)
Research and development
$326,700K
(33.73%↑ Y/Y)
Cost of revenues,
excluding amortization of...
$23,200K
Amortization of acquired
intangible assets
$16,400K
Acquired in-process
research and development
$1,500K
Net income
$144,400K
(34.33%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale debt...
$4,100K
(51.85%↑ Y/Y)
Foreign currency
translation adjustments,...
-$600K
(25.00%↑ Y/Y)
Provision for income taxes
$17,800K
(-65.77%↓ Y/Y)
Comprehensive income
$149,100K
(34.32%↑ Y/Y)
Back
Back
Income Statement
NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC (NBIX)
source: myfinsight.com